[Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO).].

Maione, A

[Angiotensin converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in microalbuminuric patients with one or more cardiovascular risk factors. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes randomized trial (LIRICO).]. [electronic resource] - Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 446-56 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1724-5990


Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin Receptor Antagonists--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Cardiovascular Diseases
Humans
Prospective Studies
Risk Factors